---
category: news
title: "AstraZeneca teams up with Renalytix AI in chronic diseases"
excerpt: "AstraZeneca (NYSE:AZN) collaborates with Renalytix AI (NASDAQ:RNLX)Â to develop and launch precision medicine strategies for cardiovascular, renal and metabolic diseases.The first stage in the collaboration will use KidneyIntelX,"
publishedDateTime: 2020-08-21T07:41:00Z
webUrl: "https://seekingalpha.com/news/3607757-astrazeneca-teams-up-renalytix-ai-in-chronic-diseases"
type: article
quality: 17
heat: 17
published: false

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - AI

secured: "H1DYW3dBdGyys+yj67/MuehZspp3t6j3m+Hs86WFZCefmRn5KEZa2bpa8u+7whHKaltDq2SOp7N3uFuzGtAS4MD2ZUM3+nzI4bW4nZMnaDo9bzJJMBzwA1pi/Z2hmSOoZzneE1VMep6flJU97AVnL0U7bDKhbxAKJF6mjppjfKlplxMFEIgppJWi60dpOnYJ7rFuZUmDIUS+FV/sXeHIAGdGRbeW1CyCA4pg5UoVy6n0be5BBeyADJOpEsy9u9cu65eyOFkfsxjkskeI86IWHXBKcF9f1O9vR62suJLRtWOkWQRliubYdkjHe67MPCrVAwArpJ1aWxQdJ6/OYyZlTA==;7DpjY853M3ROB7xMeJei9g=="
---

